{"id":"W2010059199","doi":"10.1016/j.ctrv.2013.01.002","title":"HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lapatinib; Pertuzumab; Trastuzumab; Oncology; Breast cancer; Internal medicine; Neoadjuvant therapy; Clinical trial; Targeted therapy; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004859213,0.001619462,0.03128399,0.0005753308,0.00005086873,0.00004197379,0.0006983014,0.0005008341,0.007248179],"category_scores_gemma":[0.0006024938,0.0008351121,0.00402048,0.001840111,0.0001467571,0.0001022863,0.00008129886,0.0006754259,0.0004744997],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00539908,"about_ca_system_score_gemma":0.004483171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004154501,"about_ca_topic_score_gemma":0.0001310594,"domain_scores_codex":[0.9843438,0.005112592,0.007375603,0.001247684,0.0009837135,0.0009366396],"domain_scores_gemma":[0.9916176,0.0007375827,0.004275792,0.002469724,0.0004063693,0.0004929754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00001767744,0.0002214845,0.00002131788,0.5058973,0.0008354816,0.00002681834,0.00003098197,3.832062e-8,9.240275e-7,0.00000188147,0.005243374,0.4877027],"study_design_scores_gemma":[0.0009291964,0.000255127,0.000003293094,0.5069978,0.005260452,0.00006885285,0.00000371872,5.756652e-7,0.000003295701,0.000001098507,0.48618,0.0002966801],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001197498,0.9419979,7.973655e-7,0.0007647689,0.0004518594,0.05551837,0.0008389103,0.00004919367,0.0003770357],"genre_scores_gemma":[2.663882e-7,0.9073204,0.00009175741,0.0005736791,0.0004757017,0.08930814,0.0002797023,0.0002037408,0.001746594],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.487406,"threshold_uncertainty_score":0.9996553,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3064769407507671,"score_gpt":0.523487102194639,"score_spread":0.2170101614438719,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}